Ovarian cancer in Western Australia (1982-98): Incidence, mortality and survival

Australian and New Zealand Journal of Public Health

Volumn 27, Issue 6, 2003, Pages 588-595

  Laurvick, Crystal L ^a   Semmens, James B ^a   Holman, D'Arcy J ^a   Leung, Yee C ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; AUSTRALIA; BIRTH RATE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEATH; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH HAZARD; HUMAN; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY CANCER; PUBLIC HEALTH; RISK ASSESSMENT; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0346970673     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2003.tb00604.x     Document Type: Article

References (53)

1. Australian Institute of Health and Welfare. Cancer in Australia 1998. Canberra: AIHW; 2001. AIHW Catalogue No.: CAN 12.
2. Parazzini F, Franceschi S, La Vecchia C, Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol 1991;43:9-23.
3. Whelan SL, Parkin DM, Masuyer E. Patterns of Cancer in Five Continents. Lyon (FR): International Agency for Research on Cancer (WHO); 1990. IARC Scientific Publications No.: 102.
4. Gonzalez-Diego P, Lopez-Abente G, Pollan M, Ruiz M. Time trends in ovarian cancer mortality in Europe (1955-1993). Effect of age, birth cohort and period of death. Eur J Cancer 2000;36:1816-24.
5. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
6. Partridge E, Barnes M. Epithelial ovarian cancer: Prevention, diagnosis, and treatment. CA Cancer J Clin 1999;49:297-320.
7. Daly M, Obrams GI. Epidemiology and risk assessment for ovarian cancer. Semin Oncol 1998;25:255-64.
8. Schildkraut JM, Thompson WD. Familial ovarian cancer: A population-based case-control study. Am J Epidemiol 1988;128:456-66.
9. Kristensen GB, Trope C. Epithelial ovarian carcinoma. Lancet 1997;349:113-7.
10. Scully RE. Classification of human ovarian tumours. Environ Health Perspect 1987;73:15-24.
11. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1212-20.
12. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995;62:678-84.
13. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 1997;71:948-51.
14. Friedlander ML. Prognostic factors in ovarian cancer. Semin Oncol 1998;25:305-14.
15. Pecorelli S, Odicino F, Maisonneuve P, Creasman WT, Shepherd JH, Sideri M, et al. FIGO annual report on the results of treatment in gynaecological cancer: Carcinoma of the ovary. J Epidemiol Biostat 1998;3:75-102.
16. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: Development of a health services research linked database. Aust N Z J Public Health 1999;23:453-9.
17. World Health Organization. ICD-O: International Classification of Diseases for Oncology, 2nd ed. Geneva: WHO; 1990.
18. Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas 1996, Western Australia. Canberra (ACT): ABS; 1996. Catalogue No.: 2033.5.30.001.
19. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Company; 1986.
20. Australian Bureau of Statistics. Population by Age and Sex, Australian States and Territories Population Estimates as at 30 June, 1971 on Western Australia. Canberra (ACT): ABS; 2001. ABS Catalogue No.: 3201.0.
21. SAS: Statistical Software [Computer Program]. Version 8.0. Cary (NC): SAS Institute; 1999.
22. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Ann Rev Public Health 1991;12:425-57.
23. Australian Bureau of Statistics. Births, Australia (for Years 1983-1998). Canberra (ACT): ABS; 1984-1999. ABS Catalogue No.: 3301.0.
24. Australian Bureau of Statistics. Australian Historical Population Statistics. Canberra (ACT): ABS; 2002. ABS Catalogue No.: 3105.0.65.001.
25. McDonald P, Ruzicka L, Pyne P. Marriage, fertility and mortality. In: Vamplew W, editor. Australians Historical Statistics. Broadway (NSW): Fairfax, Syme and Weldon Associates; 1987. p. 42-55.
26. Baade P, Coory M, Ring I. Cancer in Queensland. Trends in Incidence and Mortality for Selected Cancer Sites, 1982-1996. Brisbane (QLD): Health Information Centre, Queensland Health; 2000.
27. Laurvick CL, Semmens JB. Trends and outcomes for women diagnosed with ovarian cancer in Australia. Aust Fam Physician 2002;31:1005-11.
28. Coates M, Tracey E. Cancer in New South Wales, Incidence and Mortality 1997. Sydney (NSW): NSW Cancer Council; 2000.
29. Giles G, Whitfield K, Thursfield V. Cancer in Victoria 1998. Carlton (VIC): Cancer Epidemiology Centre, Anti-Cancer Council of Victoria; 2000.
30. South Australian Cancer Registry. 2000 Cancer Report - Epidemiology of Cancer in South Australia 1977-1999. Incidence, mortality and survival 1977 to 1999. Incidence and mortality (1999) analysed by type and geographical location. Twenty-three years of data. Adelaide (SA): South Australian Cancer Registry, Epidemiology Branch; 2000.
31. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1973-1998. Bethesda (MD): National Cancer Institute; 2001.
32. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988;42:690-6.
33. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990;132:446-52.
34. McDonald P. Low fertility in Australia: Evidence, causes and policy responses. People Place 2000;8:6-21.
35. Jain SK, McDonald P. Fertility of Australian birth cohorts: Components and differentials. J Aust Popul Assoc 1997;14:31-46.
36. Caldwell JC, Ware H. The evolution of family planning in Australia. Popul Stud (Camb) 1973;27:7-31.
37. Santow G. Trends in contraception and sterilization in Australia. Aust N Z J Obstet Gynaecol 1991;31:201-8.
38. Baade P, Coory M, Ring I. Cancer Survival in Queensland 1982 to 1995. Brisbane (QLD): Health Information Centre, Queensland Health; 2000.
39. Laurvick CL, Semmens JB, Leung YC, Holman CD. Ovarian cancer in Western Australia (1982-1998): Trends in surgical intervention and relative survival. Gynecol Oncol 2003;88:141-8.
40. Bjorge T, Engeland A, Hansen S, Trope CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998;75:663-70.
41. Levi F, Franceschi S, La Vecchia C, Ruzicka J, Gloor E, Randimbison L. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland. Ann Oncol 1993;4:289-94.
42. Coory M, Thompson A, Ganguly I. Cancer among people living in rural and remote Indigenous communities in Queensland. Med J Aust 2000;173:301-4.
43. O'Brien ED, Bailie RS, Jelfs PL. Cervical cancer mortality in Australia: Contrasting risk by Aboriginality, age and rurality. Int J Epidemiol 2000;29:813-6.
44. Peach HG, Pearce DC, Farish SJ. Age-standardised mortality and proportional mortality analyses of aboriginal and non-aboriginal deaths in metropolitan, rural and remote areas. Aust J Rural Health 1998;6:36-41.
45. Maher P. A review of 'traditional' aboriginal health beliefs. Aust J Rural Health 1999;7:229-36.
46. Fried O. Providing palliative care for Aboriginal patients. Aust Fam Physician 2000;29:1035-8.
47. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997;138:65-176.
48. Harris V, Sandridge A, Black R, Brewster D, Gould A. Cancer Registration Statistics Scotland 1986-1995. Edinburgh: ISD Scotland Publications; 1998.
49. Mackillop WJ, Zhang-Salomons J, Groome PA, Paszat L, Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 1997;15:1680-9.
50. Turrell G, Oldenburg B, McGuffog I, Dent R. Socioeconomic Determinants of Health: Towards a National Research Program and a Policy and Intervention Agenda. Canberra (ACT): AusInfo; 1999.
51. Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, et al. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002;2:76-84.
52. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
53. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001;98:1176-81.